Search Results for "Perphenazine Goldshield"
Original Source: Goldshield Group plc
The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between 1991 and 1993, the Group raised equity finance of £1.0 million from individual investors, many of whom are doctors, pharmacists, or from within the pharmaceutical industry. The Group became profitable in the year ended 31 March 1993.
Matching Channels
None
Matching News
Niche pharma empire-building Cinven clinches Amdipharm and Mercury deals for £832m
The European private equity firm Cinven has acquired family-owned niche pharmaceuticals company Amdipharm of the UK for £367 million, and is planning to merge it with Mercury Pharma (formerly Goldshi...
A Look At Neurocrine's VMAT-2 Inhibitor As Phase IIb Data Nears
By Jason Napodano: By Jason Napodano, CFA & John Tucker, PhD Tardive dyskinesia (TD) is a neurological disorder caused by the long-term use of psychiatric drugs (neuroleptics) used in t...
GIA announces the release of a comprehensive global report on the Social Alarms markets. Global market for Social Alarms is projected to exceed US$2.7 billion by 2018. Aging population qualifies as t...
Matching PubMed Articles
BACKGROUND AND OBJECTIVE: Despite the introduction of newer antiemetics in the prevention of postoperative nausea and vomiting (PONV), perphenazine is recommended in current guidelines, as the concept...
Perphenazine Suspension: A New, Old Treatment, Side Effects and Continuous Use.
A number of innovative delivery systems for acute antipsychotic pharmacotherapy have been developed over the years which include oral suspensions, rapidly dissolving wafers and acute intramuscular pre...
Comparison of Outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE Study.
OBJECTIVE Medication outcome literature in schizophrenia across racial-ethnic groups is sparse, with inconsistent findings. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) stud...
